New rapid screening test to detect mild cognitive impairment
A topical microbicide that silences two genes can safely protect against genital herpes infection for as long as one week, according to a joint study by researchers at the Albert Einstein College of Medicine of Yeshiva University and Harvard Medical School. The study, carried out in mice and published today in Cell Host & Microbe
Full Post: Topical microbicide protects against genital herpes
With millions of baby boomers entering late adulthood, the number of patients with Alzheimer’s disease (AD) is expected to drastically rise over the next several decades.
A team of national researchers, led by Emory University, has developed a rapid screening test to detect mild cognitive impairment (MCI) - often the earliest stage of AD. The findings are published today in the online edition of Journal of Alzheimer’s Disease .
The study shows that the combination of a very brief three-minute cognitive screening test, called the Mini-Cog (MC), with a Functional Activities Questionnaire (FAQ) - administered to a family member or friend - could accurately identify individuals with MCI and undiagnosed dementia.
“Since current medications can only delay the onset of Alzheimer’s disease but are not able to reverse its devastating effects, a test like this is key to help individuals detect this devastating disease earlier and maintain a good quality of life for as long as possible,” says James Lah, MD, associate professor of neurology, Emory University School of Medicine and lead investigator of the study.
The new screening instrument, referred to as the MC-FAQ, allowed the researchers to correctly classify the 204 participating elderly individuals as cognitively normal, demented, or mildly cognitively impaired with a high degree of accuracy (83 percent). Approximately 30 percent of participants had MCI and 32 percent were very mildly demented.
According to Lah, screening for MCI is notoriously difficult and typically requires 40-60 minutes or more of formal neuropsychological testing to achieve 80 percent accuracy or higher. Specific accuracy for classifying people as MCI with the MC-FAQ was 74 percent.
“While this may not seem overly impressive, it is quite remarkable for a 3-minute investment,” says Lah. “The MC-FAQ is also extremely inexpensive, easy to administer and score, and requires no special training.”
The MC portion of the screening consisted of a simple clock drawing task and three-item recall that typically took the research participant less than five minutes to complete. The FAQ was completed by a reliable informant, generally a spouse, other family member or close friend while the research participant was performing other tasks.
Scientists say brain scans show that education appears to lessen the effects of Alzheimer’s disease. The scientists from the Washington University School of Medicine, St. Louis, say their research supports the ‘cognitive reserve’ hypothesis and individuals with levels of higher education levels score higher on cognitive tests despite having Alzheimer’s disease. According to the hypothesis,
Full Post: Education lessens the effects of Alzheimer’s
Individuals with higher education levels appear to score higher on cognitive tests despite having evidence of brain plaques associated with Alzheimer’s disease, according to a report in the November issue of Archives of Neurology. The cognitive reserve hypothesis holds that individuals with greater cognitive (thinking, learning and memory) abilities are able to delay symptoms of
Full Post: Greater thinking, learning and memory abilities delay symptoms of Alzheimer’s disease
A test that reveals brain changes believed to be at the heart of Alzheimer’s disease has bolstered the theory that education can delay the onset of the dementia and cognitive decline that are characteristic of the disorder. Scientists at the Alzheimer’s Disease Research Center at Washington University School of Medicine in St. Louis found that
Full Post: Education delays onset of the dementia
Scientists have new information about the complex genetic signature associated with Alzheimer’s disease, the leading cause of cognitive decline and dementia in the elderly. The research, published by Cell Press in the January issue of the American Journal of Human Genetics , uses a powerful, high-resolution analysis to look for genes associated with this devastating
Full Post: New understanding of genetic signature associated with Alzheimer’s disease
One quarter of all family caregivers of Alzheimer’s disease patients succumb to the stress of providing care to a loved one and become hospital patients themselves, according to an Indiana University study published in the November 2008 issue of the Journal of General Internal Medicine. Researchers from the Indiana University School of Medicine, the
Full Post: Study finds 25% of family caregivers of AD patients go to ER or are hospitalized